PNC Financial Services Group’s Entrada Therapeutics TRDA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-200	Closed	-$3.03K	–	4758
2023 Q2	$3.03K	Hold	200	–	–	﹤0.01%	4250
2023 Q1	$2.9K	Buy	+200	New	+$2.9K	﹤0.01%	4212